Peptide Drug R&D Document Structured Analysis: Reference and

Data Characteristics

Peptide drug R&D documents come from various sources. These include in vitro experiment reports, in vivo efficacy evaluations, preclinical study data, and synthesis process records. Documents are typically in PDF or DOCX format. They contain both structured and unstructured information. Structured information, such as peptide sequences, molecular weights, purity, batch numbers, experimental conditions, IC50/EC50 values, and pharmacokinetic parameters, often appears in tables. Unstructured information includes experimental procedure descriptions, results analysis, discussions, and conclusions. Document update frequencies vary. Basic research data is relatively stable, while clinical trial reports may update frequently with phase advancements. Field naming sometimes differs between laboratories or project teams. Units strictly follow international standards, such as molar concentration, mass concentration, and time units.

Constraints on "Reference and Traceability"

The heterogeneous nature of peptide drug R&D document data sources requires a reference traceability mechanism. This mechanism must handle multiple file formats and extract critical structured data from complex tables. Varying update frequencies mean the system needs version management. This ensures traced references are valid at a specific point in time. Inconsistent field naming challenges index building and query matching. Synonym mapping or semantic understanding is needed to enhance recall accuracy. Key information, such as peptide sequences and activity data, demands high accuracy. Any reference must precisely point to the original source, including specific page numbers, table row numbers, or paragraphs. This constrains recall granularity. It must be detailed to the text block level to avoid misleading references.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`maxContext`	`800–1200 characters`	Ensures recalled snippets have sufficient context while avoiding information redundancy. This facilitates peptide sequence and activity data parsing.
`Recall count`	`Top 5`	Prioritizes returning the most relevant few snippets. This reduces irrelevant information interference and improves traceability efficiency.
`Similarity threshold`	`0.75–0.85`	Balances recall breadth and precision. This ensures finding highly relevant snippets like peptide names and experimental conditions.
`Chunk size`	`300–500 characters`	Accommodates potentially long paragraph descriptions in peptide experiment reports. This ensures semantic integrity of segments.
`Rerank result count`	`Top 3`	Re-ranks results after initial recall. This further optimizes ranking and highlights the most direct references.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Allows ample parsing time for large peptide clinical reports, which may contain hundreds of pages.

Common Pitfalls

Recall content does not increase, even after lowering the similarity threshold and increasing the recall limit. This happens because the indexing segmentation strategy fails to effectively capture semantic boundaries in peptide documents. Multiple related pieces of information are merged into a single segment.
The source_id field in the output reference source is empty. This occurs when the original file identifier is not correctly extracted or associated from metadata during file upload.
The system fails to maintain conversation context during continuous questioning. The second question cannot use peptide information confirmed in the first question. This happens when the session management mechanism does not correctly bind knowledge base session states.

Verification Steps

Select a typical document containing peptide sequences, IC50 values, and experimental conditions. Ask targeted questions. Verify that the returned reference sources precisely point to specific page numbers or table areas in the document. Confirm that extracted key information matches the original text.
Upload a batch of documents with different naming conventions and unit representations. After indexing, use keyword searches to verify if the system can successfully recall relevant information through synonym mapping or semantic understanding.
Simulate a multi-turn conversation. In the first turn, specify a peptide. In the second turn, ask about that peptide's pharmacokinetic characteristics. Check if the system can correctly trace and cite information from the knowledge base without repeating the peptide name.

The values given are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.